Megakaryon

Megakaryon's goal is to clinically apply this technology and achieve the practical use of iPS cell-derived platelet products. By collaborating with academic research institutions and companies both in China and internationally, we have established production techniques to stably provide safe platelet products, realizing the "second innovation" in transfusion medicine and contributing to the development of medical infrastructure in Japan and around the world.